Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2000

View Archived Issues

Researchers urge development of tuberculosis vaccine

Schwabe to provide Ginkgo biloba extract for NIH study

Enrollment complete for phase III trial of WF-10 for late-stage HIV disease

Newly discovered protein determines cell morphology

Pravastatin's effects on stroke in MI patients

Zyban may reduce weight gain in smoking cessation

Bausch & Lomb and Muro to copromote Optivar

MGI Pharma and MethylGene to collaborate on DNA MeTase inhibitor development

Phase II SBIR grant awarded to Aastrom Bioscience for dendritic cell immunotherapy research

Isis Pharmaceuticals division to work with R.W. Johnson on antisense target validation

Targeted Genetics to acquire Genovo, collaborate with Biogen

Avanir licenses dextromethorphan product for CNS indications

Roche's CellCept approved for third organ rejection indication

Zarix updates progress on Thymitaq

Antiestrogen prevents obesity and related metabolic conditions in ovariectomized rats

Synaptic vesicle transporter for glutamate discovered: VGLUT1

Researchers determine crystal structure of large ribosomal subunit

Orally bioavailable benzthiazolylalanine thrombin inhibitors developed

New compounds interacting with CCR5 under development at Takeda

Novel endothelin receptor antagonists under study at BASF

U.K. clinical hold on Invicorp removed

Novel PCP inhibitors under development at Roche

New compounds interacting with NK1 receptor useful for pain, etc.

New compounds interacting with GABA receptor useful for anxiety, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...